The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Weiss Lawrence Martin since 2020.
This trader's CIK number is 1761625.
At the time of last reporting, Weiss Lawrence Martin was the Chief Medical Officer of Neogenomics Inc. (stock ticker symbol NEO).
Also see all insider trading activities at Neogenomics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | NEO | 0 | $0 | 0 | $0 | 25,050 | $477,202 |
| 2020 | NEO | 0 | $0 | 20,200 | $1,031,412 | 109,004 | $1,241,337 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-04-22 | NEO | Option Ex | 25,050 | 19.05 | 477,202 |
| 2020-12-14 | NEO | Sale | 20,200 | 51.06 | 1,031,412 |
| 2020-12-14 | NEO | Option Ex | 109,004 | 11.39 | 1,241,337 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Weiss Lawrence Martin (Chief Medical Officer of Neogenomics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.